DDDD 4d Pharma Plc

TIDMDDDD

RNS Number : 0605Q

AIM

16 February 2023

NOTICE

16/02/2023 - 07:00

NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM

Pursuant to AIM Rule 41 the following securities have been cancelled from trading on AIM with effect from the time and date of this notice.

 
4D PHARMA PLC 
213800O49VYSXWE2ZD52 
ORDINARY SHARES  (BJL5BR0)(GB00BJL5BR07)  4D PHAR/PAR VTG FPD 0.0025 
 OF 0.25P EACH, 
 FULLY PAID 
                 -----------------------  -------------------------- 
 

If you have any queries or require further information, please contact the company's nominated adviser.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

AMOUVSNROKUUAAR

(END) Dow Jones Newswires

February 16, 2023 02:00 ET (07:00 GMT)

4d Pharma (LSE:DDDD)
Historical Stock Chart
From Nov 2024 to Dec 2024

4d Pharma (LSE:DDDD)
Historical Stock Chart
From Dec 2023 to Dec 2024